Skip to main content

What the FDA labels say about taking them together

Busulfan and deferasirox

Busulfan's FDA label of June 27, 2024 names deferasirox in its drug interactions section, and deferasirox's label names busulfan too. The busulfan label: “Decreased clearance of busulfan was observed with concomitant use with deferasirox.”

Check it at the source: the busulfan FDA label on DailyMed (effective June 27, 2024, Eugia US LLC); the deferasirox FDA label on DailyMed (effective January 28, 2026, Novartis Pharmaceuticals Corporation).

What does the busulfan label say about deferasirox?

Busulfan label, drug interactions

Decreased clearance of busulfan was observed with concomitant use with deferasirox.

Source: FDA drug label (Busulfan), Eugia US LLC, effective June 27, 2024 (SPL set 06883ac0-4b2a-4f26-89bf-512d37b9ba7f), via openFDA; the full label on DailyMed

What does the deferasirox label say about busulfan?

Deferasirox label, drug interactions

Consider repaglinide dose reduction and monitor blood glucose levels. ( 7.3 ) Avoid the use of Exjade with CYP1A2 substrate theophylline. ( 7.4 ) Deferasirox increases exposure of busulfan.

Source: FDA drug label (Jadenu, NDA206910), Novartis Pharmaceuticals Corporation, effective December 11, 2025 (SPL set fee89140-fff1-4443-9f42-24ac004fcda1), via openFDA

Source: FDA drug label (Exjade), Novartis Pharmaceuticals Corporation, effective January 28, 2026 (SPL set 3495a70c-870c-4968-940e-8baea152cf85), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

7Busulfan generic labelers
20Deferasirox generic labelers
BusulfanDeferasirox
Labeled forLeukemia, lymphoma and myeloman/a
Boxed warningYesYes
Pharmacy cost (NADAC)n/a$1.25 per tablet 360 mg tablet
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?